LFST
Lifestance Health Group Inc
NASDAQ · Health Care
$6.83
+0.29 (+4.43%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 1.28B | 1.04B | 1.06B | 1.05B | 1.13B |
| Net Income | -58,933,539 | -43,020,670 | 124.57M | 133.52M | 137.54M |
| EPS | — | — | — | — | — |
| Profit Margin | -4.6% | -4.4% | 11.7% | 12.8% | 12.2% |
| Rev Growth | +23.3% | +23.3% | +13.7% | +11.8% | +21.1% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 220.02M | 220.02M | 963.36M | 857.02M | 789.23M |
| Total Equity | 1.11B | 1.11B | 916.70M | 784.97M | 776.37M |
| D/E Ratio | 0.20 | 0.20 | 1.05 | 1.09 | 1.02 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 40.92M | 31.53M | 160.34M | 155.45M | 166.72M |
| Free Cash Flow | — | — | 110.21M | 174.76M | 140.76M |